The Affimer is a revolutionary new engineered affinity protein. This video animation gives an overview of some of the key benefits, features and applications of Affimer technology. It explains why Affimer reagents and therapeutics are uniquely suited to a wide range of applications where antibodies and aptamers have limitations.
Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.